Overall rank by patents
#23,484
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 2 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
According to USPTO PatentsView, Surgimatix ranks #23,484 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R23484 · US Corporation #23,484 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Sumitomo Dainippon Pharma Oncology, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Art Design Works · near
26 score
IPEE · near
26 score
Tuper S/a · near
26 score
Surgimatix · this assignee
26 score
CSG Systems · near
26 score
3D Lighting Innovati… · lowest
7 score
What this shows Surgimatix's Innovation Score is 25.5/100 (top 82% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Surgimatix, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2016. By volume, Surgimatix sits between Sumitomo Dainippon Pharma Oncology, Inc. and Symbolic Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Sumitomo Dainippon Pharma Oncology, Inc.
12 patents
Sundrop Fuels, Inc.
12 patents
Superb AI Co., Ltd.
12 patents
Surfacide, LLC
12 patents
Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences
12 patents
Swirlds, Inc.
12 patents
Sy Kessler Sales, Inc.
12 patents
Symbolic LLC
12 patents
Surgimatix, Inc.
12 patents
What this shows Surgimatix holds 12 patents at rank #23,480, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,480 in granted patent volume.
Other assignees with the most granted patents in Surgimatix's primary technology class.
Two PlainPatent-derived peer sets for Surgimatix, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (26 here).
Surgimatix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 Top 82% higher than 18% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 8.3% |
| 2017 | 2 | 16.7% |
| 2018 | 5 | 41.7% |
| 2019 | 4 | 33.3% |
Top 2 of 2 technology areas
Overall rank by patents
#23,484
of 50,000 tracked assignees
25.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.